Compare Arimidex vs. Xeloda

Head-to-head comparisons of medication uses, side effects, ratings, and more.

Arimidex (Anastrozole)

Xeloda (Capecitabine)

No information currently available

Upsides

No information currently available

Downsides

No information currently available

Used for

Breast cancer
Adjuvant
Postmenopausal
Hormone receptor-positive. Breast cancer
Advanced
Postmenopausal
Following tamoxifen therapy. Breast cancer
Locally advanced or metastatic
Postmenopausal
Hormone receptor-positive or unknown
First-line
Breast cancer
Neoadjuvant treatment for hormone receptor-positive
Operable or potentially operable
Locally advanced disease in postmenopausal women. Breast cancer
Postmenopausal women at high risk; Prophylaxis

Colon cancer
Adjuvant therapy
Duke's Stage C
When treatment with a fluoropyrimidine alone is preferred. Metastatic breast cancer
In combination with docetaxel after failure of prior anthracycline-containing regimens. Metastatic breast cancer
Monotherapy
When resistant to paclitaxel/anthracycline-containing regimens or resistant to paclitaxel and not a candidate for further anthracycline therapy. Metastatic colorectal cancer
First-line therapy when treatment with a fluoropyrimidine alone is preferred.
Colon cancer
Adjuvant therapy
Stage III
In combination with oxaliplatin. Colorectal cancer
Unresectable
Advanced
Or metastatic; first-line in combination with oxaliplatin. Esophagogastric cancer
Advanced or metastatic
In combination with chemotherapeutic agents. Esophagogastric cancer
First-line therapy for advanced or metastatic disease
In combination with epirubicin and oxaliplatin or cisplatin. Gastric cancer
First-line therapy for advanced or metastatic disease
In combination with chemotherapeutic agents. Gastric cancer
First-line therapy for advanced or metastatic disease
In combination with epirubicin and oxaliplatin or cisplatin. Gastric cancer
Stage II to IIIB
Adjuvant therapy in combination with oxaliplatin. Malignant tumor of rectum
Locally advanced
Adjuvant or neoadjuvant therapy
In combination with radiotherapy. Metastatic breast cancer
HER2 overexpression
In combination with trastuzumab. Metastatic breast cancer
In combination with bevacizumab in patients previously treated with an anthracycline and a taxane. Metastatic colorectal cancer
Combination therapy with irinotecan. Metastatic colorectal cancer
First-line therapy
In combination with bevacizumab and oxaliplatin. Metastatic renal cell carcinoma. Ovarian cancer. Pancreatic cancer
Monotherapy.